Sign In
Buy SGTX
$22.47
+0 (+0%)
At Close: Nov 09, 2023
Lilly Completes Acquisition of Sigilon Therapeutics
07:25am, Monday, 14'th Aug 2023
INDIANAPOLIS , Aug. 14, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Sigilon Therapeutics, Inc. (NASDAQ: SGTX). The acquisit
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Sigilon Ther
Sigilon (SGTX) Skyrockets 441% on Buyout Offer From Eli Lilly
10:43am, Friday, 30'th Jun 2023
Eli Lilly (LLY) is set to acquire Sigilon (SGTX) for $14.92 per share, in cash, along with a contingent value right of $111.64 per share.
Eli Lilly to buy Sigilon Therapeutics on a massive premium
01:50pm, Thursday, 29'th Jun 2023
Shares of Sigilon Therapeutics Inc (NASDAQ: SGTX) soared more than 500% today after Eli Lilly & Co (NYSE: LLY) said it will buy the biopharmaceutical company in a deal worth up to $309.6 million. Deta
Eli Lilly to Acquire Sigilon Therapeutics
12:55pm, Thursday, 29'th Jun 2023
Eli Lilly said it will acquire Sigilon Therapeutics in an all-cash deal worth up to $309.6 million.
Eli Lilly to buy Sigilon Therapeutics to expand diabetes treatments
08:13am, Thursday, 29'th Jun 2023
Eli Lilly and Co said on Thursday it will acquire all the shares of Sigilon Therapeutics that it did not own to gain access to experimental cell therapies that can provide longer-term solutions for di
Why Is Sigilon Therapeutics (SGTX) Stock Up 691% Today?
07:59am, Thursday, 29'th Jun 2023
Sigilon Therapeutics (NASDAQ: SGTX ) stock is rocketing on Thursday morning after Eli Lilly (NYSE: LLY ) agrees to acquire the company. The acquisition will see Eli Lilly pay $14.92 per share in cash
Lilly to Acquire Sigilon Therapeutics
06:45am, Thursday, 29'th Jun 2023
INDIANAPOLIS and CAMBRIDGE, Mass. , June 29, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Sigilon Therapeutics, Inc. (Nasdaq: SGTX) today announced a definitive agreement for Lilly to
Sigilon Therapeutics to Present at the Needham Virtual Healthcare Conference
07:00am, Tuesday, 18'th Apr 2023
CAMBRIDGE, Mass., April 18, 2023 (GLOBE NEWSWIRE) -- Sigilon Therapeutics, Inc. (NASDAQ: SGTX), a biotechnology company that seeks to develop functional cures for acute and chronic diseases through it
10 Best-Performing Penny Stocks in the Health Care Sector
10:49pm, Monday, 03'rd Apr 2023
The healthcare sector has more high return generating companies than many other sectors.
Sigilon Therapeutics, Inc. (SGTX) Reports Q2 Loss, Tops Revenue Estimates
07:33pm, Thursday, 04'th Aug 2022
Sigilon Therapeutics, Inc. (SGTX) delivered earnings and revenue surprises of 4.35% and 22.68%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stoc
Sigilon Therapeutics, Inc. (SGTX) Reports Q1 Loss, Tops Revenue Estimates
06:48pm, Thursday, 12'th May 2022
Sigilon Therapeutics, Inc. (SGTX) delivered earnings and revenue surprises of -43.33% and 27.62%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the s
Sigilon Therapeutics to Present at the Needham Healthcare Conference
07:00am, Thursday, 07'th Apr 2022
CAMBRIDGE, Mass., April 07, 2022 (GLOBE NEWSWIRE) -- Sigilon Therapeutics, Inc. (NASDAQ: SGTX), a biotechnology company that seeks to develop functional cures for chronic diseases through its Shielded
Sigilon Therapeutics (SGTX) Investor Presentation - Slideshow
05:38am, Thursday, 17'th Mar 2022 Seeking Alpha
Sigilon Therapeutics GAAP EPS of -$0.55, revenue of $1.99M (NASDAQ:SGTX)
09:45pm, Monday, 14'th Mar 2022 Seeking Alpha
Sigilon Therapeutics press release (SGTX): GAAP EPS of -$0.55.Revenue of $1.99M (-46.9% Y/Y).
